Moderna, Inc. - stock earnings
MRNA Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 BeforeMarket | -3.07 / -3.65 | - | 167.0 million / 99.5 million | - |
MRNA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 217.0 million USD | 2.8 billion USD |
| 2023Q3 | -3.6 billion USD | 1.8 billion USD |
| 2023Q2 | -1.4 billion USD | 344.0 million USD |
| 2023Q1 | 79.0 million USD | 1.9 billion USD |
| 2022Q4 | 1.5 billion USD | 5.1 billion USD |
| 2022Q3 | 1.0 billion USD | 3.2 billion USD |
| 2022Q2 | 2.2 billion USD | 4.6 billion USD |
| 2022Q1 | 3.7 billion USD | 5.9 billion USD |
| 2021Q4 | 4.9 billion USD | 6.9 billion USD |
| 2021Q3 | 3.3 billion USD | 4.8 billion USD |
| 2021Q2 | 2.8 billion USD | 4.2 billion USD |
| 2021Q1 | 1.2 billion USD | 1.7 billion USD |
| 2020Q4 | -272.5 million USD | 229.4 million USD |
| 2020Q3 | -233.6 million USD | 12.2 million USD |
| 2020Q2 | -116.7 million USD | 28.4 million USD |
| 2020Q1 | -124.2 million USD | 4.5 million USD |
| 2019Q4 | -124.2 million USD | 10.6 million USD |
| 2019Q3 | -123.2 million USD | 13.3 million USD |
| 2019Q2 | -135.1 million USD | 10.0 million USD |
| 2019Q1 | -131.1 million USD | 14.1 million USD |
| 2018Q4 | -141.4 million USD | 32.8 million USD |
| 2018Q3 | -80.3 million USD | 36.7 million USD |
| 2018Q2 | -90.6 million USD | 25.8 million USD |
| 2018Q1 | -72.4 million USD | 27.5 million USD |
| 2017Q4 | -37.9 million USD | 88.4 million USD |
| 2017Q3 | -64.7 million USD | 42.5 million USD |
| 2017Q2 | 994363 USD | ? USD |
| 2017Q1 | -1.1 million USD | ? USD |
| 2016Q4 | -216.2 million USD | 108.4 million USD |
MRNA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -4.7 billion USD | 6.8 billion USD |
| 2022 | 8.4 billion USD | 19.3 billion USD |
| 2021 | 12.2 billion USD | 17.7 billion USD |
| 2020 | -747.1 million USD | 274.5 million USD |
| 2019 | -514.0 million USD | 48.0 million USD |
| 2018 | -384.7 million USD | 122.5 million USD |
| 2017 | -255.9 million USD | 177.0 million USD |
| 2016 | -216.2 million USD | 101.5 million USD |
| 2015 | -1.1 million USD | ? USD |
| 2014 | -6.5 million USD | 500000 USD |
MRNA
Price: $125.59
52 week price:
Earnings Per Share: -12.33 USD
P/E Ratio: -10.56
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 3.3 million
Market Capitalization: 42.1 billion